Overactive Bladder

Efficacy and safety of onabotulinumtoxinA in patients with overactive bladder: subgroup analyses by sex and by serum prostate-specific antigen levels in men from a randomized controlled trial. July 25, 2021

Low Intensity Extracorporeal Shock Wave Therapy as a Potential Treatment for Overactive Bladder Syndrome. July 25, 2021

Acupuncture in addition to standard conservative treatment for overactive bladder; a feasibility trial for a randomized controlled study. July 25, 2021

Urogynecological survey in a group of Italian women treated for overactive bladder: Symptoms and quality of life analysis during the Covid-19 period. July 18, 2021

The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US. July 18, 2021

Pelvic organ prolapse surgery and overactive bladder symptoms-a population-based cohort (FINPOP). July 11, 2021

Association between overactive bladder and pelvic organ mobility as evaluated by dynamic magnetic resonance imaging. July 4, 2021

Patient Perceptions Impact Progression to Third Line Therapy for Treatment of Overactive Bladder. July 4, 2021

Axonics® System for Treatment of Overactive Bladder Syndrome and Urinary Urgency Incontinence. July 4, 2021

Do we need more patient-friendly treatment options for overactive bladder (OAB)? June 27, 2021

Transcutaneous electrical nerve stimulation and solifenacin succinate versus solifenacin succinate alone for treatment of overactive bladder syndrome: A double-blind randomized controlled study. June 27, 2021

Overactive bladder phenotypes: development and preliminary data. June 20, 2021

Gene Therapy for Overactive Bladder: A Review of BK-Channel α-Subunit Gene Transfer. June 13, 2021

Mirabegron versus Solifenacin in Children with Overactive Bladder: Prospective Randomized Single-Blind Controlled Trial. June 13, 2021

Laparoscopic removal of intravesically inserted transobturator tape. June 13, 2021

Cost-Effectiveness Analysis Between Sacral Neuromodulation and OnabotulinumtoxinA for the Treatment of Refractory Overactive Bladder in Women: A Systematic Review. June 6, 2021

Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients. June 6, 2021

What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine. May 30, 2021

Urodynamic and clinical features in women with overactive bladder: When to suspect concomitant voiding dysfunction? May 30, 2021

Treatment for overactive bladder: A meta-analysis of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation. May 23, 2021

Page 1 of 95